Page last updated: 2024-08-24

glucose, (beta-d)-isomer and edotecarin

glucose, (beta-d)-isomer has been researched along with edotecarin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arakawa, H; Egashira, S; Fukasawa, K; Hara, Y; Matsumoto, M; Morishima, H; Nakai, K; Nishimura, S; Ohkubo, M; Yoshinari, T1
Arakawa, H; Kodera, T; Morishima, H; Morita, M; Nishimura, S; Ohkubo, M; Okura, A1
Arakawa, H; Honma, T; Kawamoto, H; Morishima, H; Nakano, M; Nishimura, S; Nishimura, T; Ohkubo, M; Suda, H; Yoshinari, T1
Arakawa, H; Hara, Y; Komatani, H; Kotani, H; Matsumoto, M; Nakagawa, R; Nishimura, S1
Bigner, DD; Cavazos, CM; Friedman, HS; Keir, ST; Yoshinari, T1

Other Studies

5 other study(ies) available for glucose, (beta-d)-isomer and edotecarin

ArticleYear
Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I.
    Cancer research, 1999, Sep-01, Volume: 59, Issue:17

    Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line; DNA; Enzyme Inhibitors; Glucosides; Humans; Indoles; Mice; Sodium Chloride; Topoisomerase I Inhibitors

1999
In vivo anti-tumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice.
    Japanese journal of cancer research : Gann, 1999, Volume: 90, Issue:10

    Topics: Animals; Antineoplastic Agents; Body Weight; Breast Neoplasms; Carbazoles; Cisplatin; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Glucosides; Humans; Indoles; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasms; Paclitaxel; Prostatic Neoplasms; Time Factors

1999
Synthesis and biological activities of NB-506 analogues modified at the glucose group.
    Bioorganic & medicinal chemistry letters, 2000, Mar-06, Volume: 10, Issue:5

    Topics: Antineoplastic Agents; Carbazoles; Enzyme Inhibitors; Glucose; Glucosides; Humans; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Stereoisomerism; Topoisomerase I Inhibitors; Tumor Cells, Cultured

2000
Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
    Cancer research, 2001, Apr-01, Volume: 61, Issue:7

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Carbazoles; Colonic Neoplasms; DNA, Complementary; DNA, Neoplasm; Drug Resistance, Multiple; Enzyme Inhibitors; Fibroblasts; Gene Expression Profiling; Glucosides; Humans; Indoles; Lung Neoplasms; Mice; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Topoisomerase I Inhibitors; Transfection; Tumor Cells, Cultured

2001
Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against pediatric and adult central nervous sy
    Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:3

    Topics: Adult; Animals; Antineoplastic Agents; Brain Neoplasms; Carbazoles; Child; Enzyme Inhibitors; Female; Glioma; Glucosides; Humans; Indoles; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Nude; Neoplasm Transplantation; Survival Rate; Topoisomerase I Inhibitors; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured

2001
chemdatabank.com